Emphasis on Alternatives and Enhanced Oversight
The Humane and Existing Alternatives in Research and Testing Sciences (HEARTS) Act, introduced in February, will help “ensure that non-animal methods are prioritized, where applicable and feasible, in proposals for all research to be conducted or supported by the National Institutes of Health.” The bill states what AAVS and many other advocates have long believed, that animal welfare “oversight is generally weak and little heed is paid to the use of non-animal methods or the avoidance of duplication, thereby unnecessarily subjecting animals to pain, suffering, and death.”
Currently, researchers just have to show that they’ve considered alternatives to animals. The HEARTS Act, however, would require researchers to do a harm benefit analysis to ‘justify’ their use of animals.
Contact your federal Representative and ask that s/he support the HEARTS Act (H.R. 1209). Tell him/her that alternatives save animals!
Earlier this year, scientists in China announced the birth of two monkey clones, claiming they can be used as ‘models’ of human disease. While mainstream media reported on this with an angle tying it to human cloning, little attention was given to the ethical dilemma of animal cloning itself. In this piece, a bioethicist, David Hunter, clearly outlines the animal welfare concerns involved animal cloning and using animal models of human disease. READ MORE »
We are excited that the popular beauty blog, Natch Beaut, recently featured the Leaping Bunny Program, a cruelty-free certification chaired by AAVS. Leaping Bunny’s Kim and Caitlin were interviewed and, in a fun and informative way, talked about what’s going on in China, alternatives to animal testing, and why the Leaping Bunny Logo is so important. Check it out! It’s a great overview of the cruelty-free beauty movement. To listen, follow the link, click on the pink button on the right, and choose the 2/15/2019 interview. LISTEN HERE »
Vanda Pharmaceuticals took the dramatic step of filing a lawsuit against the FDA, alleging that the agency is forcing it to do unnecessary testing on dogs. The company has developed a new drug and wants to start human clinical trials, but FDA has put a hold on this testing until Vanda conducts a nine-month toxicity study using dogs. However, Vanda says that there is already sufficient data showing the new drug is safe and that killing “dozens of dogs” is unnecessary. READ MORE »